(Q34636943)

3 August 2017

1 reference

title

Evolving perspectives in product safety for haemophilia (English)

1 reference

3 August 2017

0 references

Farrugia A

1

1 reference

3 August 2017

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

8

1 reference

3 August 2017

236-243

1 reference

3 August 2017

3

1 reference

The impact of improved safety on maintaining a sufficient blood supply

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

The potential impact of incentives on future blood donation behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

Transfusion medicine. First of two parts--blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

The transfusion-associated transmission of parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

Reducing the risk of infection from plasma products: specific preventative strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

Clinical studies with solvent detergent-treated products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

Nanofiltration, a new specific virus elimination method applied to high-purity factor IX and factor XI concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

SEN virus infection and its relationship to transfusion-associated hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

Scrapie removal using Planova virus removal filters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

The hemophilias--from royal genes to gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00596.X

10.1046/J.1365-2516.2002.00596.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12010417